Prominent Accumulation in Hemodialysis Patients of Solutes Normally Cleared by Tubular Secretion

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 615-622

  Sirich, Tammy L ^a   Funk, Benjamin A ^a   Plummer, Natalie S ^a   Hostetter, Thomas H ^b   Meyer, Timothy W ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CRESOL SULFATE; CREATININE; GLUTAMINE DERIVATIVE; HIPPURIC ACID; INDICAN; PARA CRESOL; PHENYLACETYLGLUTAMINE; UNCLASSIFIED DRUG; UREA;

ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CASE CONTROL STUDY; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIFFUSION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KIDNEY TUBULE EXCRETION; MAINTENANCE THERAPY; MATHEMATICAL MODEL; PRIORITY JOURNAL; SOLUTE; UREA BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CRESOLS; FEMALE; GLUTAMINE; HIPPURATES; HUMANS; INDICAN; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; MALE; MIDDLE AGED; MODELS, STATISTICAL; RENAL DIALYSIS;

EID: 84896897434     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060597     Document Type: Article

References (39)

1. Depner TA: Prescribing Hemodialysis: A Guide to Urea Modeling, Norwall, MA, Kluwer Academic Publishers, 1991
2. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE: Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 21: 1041-1051, 2010
3. Itoh Y, Ezawa A, Kikuchi K, Tsuruta Y, Niwa T: Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 403: 1841-1850, 2012
4. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23: 1258-1270, 2012
5. Sirich TL, Aronov PA, Plummer NS, Hostetter TH, Meyer TW: Numerous protein-bound solutes are cleared by the kidney with high efficiency. Kidney Int 84: 585-590, 2013
6. Schneditz D, Platzer D, Daugirdas JT: A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis. Nephrol Dial Transplant 24: 2218-2224, 2009
7. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R: Intradialytic removal of protein-bound uraemic toxins: Role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 15: 50-57, 2000 (Pubitemid 30037930)
8. Meyer TW, Leeper EC, Bartlett DW, Depner TA, Lit YZ, Robertson CR, Hostetter TH: Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol 15: 1927-1935, 2004 (Pubitemid 38822074)
9. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P: Protein-bound toxins - update 2009. Semin Dial 22: 334-339, 2009
10. Gulyassy PF, Depner TA: Impaired binding of drugs and endogenous ligands in renal diseases. Am J Kidney Dis 2: 578-601, 1983 (Pubitemid 13078634)
11. Mingrone G, De Smet R, Greco AV, Bertuzzi A, Gandolfi A, Ringoir S, Vanholder R: Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin. Clin Chim Acta 260: 27-34, 1997 (Pubitemid 27136410)
12. Klammt S, Wojak HJ, Mitzner A, Koball S, Rychly J, Reisinger EC, Mitzner S: Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins. Nephrol Dial Transplant 27: 2377-2383, 2012
13. Schmidt S, Gonzalez D, Derendorf H: Signi ficance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci 99: 1107-1122, 2010
14. Liu X, Chen C, Hop CE: Do we need to optimize plasma protein and tissue binding in drug discovery? Curr Top Med Chem 11: 450-466, 2011
15. von Winckelmann SL, Spriet I, Willems L: Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy 28: 1391-1400, 2008
16. Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder R: Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 40: 339-347, 2002 (Pubitemid 34827652)
17. Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P: p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 4: 1932-1938, 2009
18. Eloot S, Torremans A, De Smet R, Marescau B, DeDeyn PP, Verdonck P, Vanholder R: Complex compartmental behavior of small water-soluble uremic retention solutes: Evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50: 279-288, 2007 (Pubitemid 47095079)
19. Jonker JW, Schinkel AH: Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308: 2-9, 2004 (Pubitemid 38090693)
20. Sekine T, Miyazaki H, Endou H: Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290: F251-F261, 2006 (Pubitemid 43724979)
21. Nigam SK, Bush KT, Bhatnagar V: Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 3: 443-448, 2007 (Pubitemid 47123587)
22. Burckhardt G: Drug transport by Organic Anion Transporters (OATs). Pharmacol Ther 136: 106-130, 2012
23. Eraly SA, Vallon V, Vaughn DA, Gangoiti JA, Richter K, Nagle M, Monte JC, Rieg T, Truong DM, Long JM, Barshop BA, Kaler G, Nigam SK: Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem281: 5072-5083, 2006 (Pubitemid 43847773)
24. Wikoff WR, Nagle MA, Kouznetsova VL, Tsigelny IF, Nigam SK: Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res 10: 2842-2851, 2011
25. Cathcart-Rake W, Porter R, Whittier F, Stein P, Carey M, Grantham J: Effect of diet on serum accumulation and renal excretion of aryl acids and secretory activity in normal and uremic man. Am J Clin Nutr 28: 1110-1115, 1975
26. MacArthur RB, Altincatal A, Tuchman M: Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers. Mol Genet Metab 81[Suppl 1]: S67-S73, 2004 (Pubitemid 38402238)
27. Vanholder R, Schepers E, Pletinck A, Neirynck N, Glorieux G: An update on protein-bound uremic retention solutes. J Ren Nutr 22: 90-94, 2012
28. Pham NM, Recht NS, Hostetter TH, Meyer TW: Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis. Clin J Am Soc Nephrol 3: 85-90, 2008
29. Vanholder R, Meert N, Van Biesen W, Meyer T, Hostetter T, Dhondt A, Eloot S:Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes? Nat Clin Pract Nephrol 5: 130-131, 2009
30. Bricker NS, Klahr S, Lubowitz H, Rieselbach RE: Renal function in chronic renal disease. Medicine (Baltimore) 44: 263-288, 1965
31. Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B: Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Clin J Am Soc Nephrol 8: 1508-1514, 2013
32. Marquez IO, Tambra S, Luo FY, Li Y, Plummer NS, Hostetter TH, Meyer TW: Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6: 290-296, 2011
33. Sirich TL, Luo FJ, Plummer NS, Hostetter TH, Meyer TW: Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant 27: 1574-1579, 2012
34. Niwa T: Organic acids and the uremic syndrome: Protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 16: 167-182, 1996
35. Schepers E, Glorieux G, Vanholder R: The gut: The forgotten organ in uremia? Blood Purif 29: 130-136, 2010
36. Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW: Colonic contribution to uremic solutes. J Am Soc Nephrol 22: 1769-1776, 2011
37. Meijers BK, Evenepoel P: The gut-kidney axis: Indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 26: 759-761, 2011
38. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL: Chronic kidney disease alters intestinal microbial flora. Kidney Int 83: 308-315, 2013
39. Poesen R, Meijers B, Evenepoel P: The colon: An overlooked site for therapeutics in dialysis patients. Semin Dial 26: 323-332, 2013